Medicamentos e Infodemia

análise de mídias sociais no primeiro ano da pandemia de COVID-19

Autores

DOI:

https://doi.org/10.21680/2447-0198.2022v6n0ID27214

Palavras-chave:

Covid-19, Medicamentos, Pandemia, Mídia social

Resumo

O primeiro ano da pandemia da COVID-19 trouxe avanços científicos críticos a velocidades nunca vistas. As informações científicas conquistaram o mundo nas notícias e nas redes sociais. No entanto, a disseminação de fake news consolidou uma infodemia entre uma doença ainda desconhecida e nenhum tratamento comprovado cientificamente. O presente estudo teve como objetivo avaliar o conteúdo e o tipo de informação sobre medicamentos indicados para o tratamento da COVID-19 sem evidências científicas nas redes sociais brasileiras. Duas redes sociais, Instagram e Twitter, foram selecionadas para pesquisar informações sobre medicamentos relacionadas à prevenção ou tratamento da COVID-19. A pesquisa foi realizada com as hashtags: #cloroquina, #hidroxicloroquina, #ivermectina e #nitazoxanida para publicações em português em março de 2020 e 2021. Estatística descritiva foi utilizada para a apresentação dos dados quantitativos. Em 2020, a cloroquina foi o medicamento com maior número de publicações nas duas redes sociais analisadas. As publicações abordaram as evidências de uso e escassez do medicamento, sendo a grande maioria considerada informação correta. Já em 2021, a ivermectina foi predominante no Instagram, enquanto a cloroquina foi a mais publicada no Twitter. Ambos os medicamentos foram relacionados ao “tratamento precoce” e ao conteúdo político-ideológico, classificadas principalmente como desinformação. Assim, é necessário reforçar as diretrizes das mídias sociais para reduzir a disseminação da desinformação em saúde para a população. Ao mesmo tempo, a educação em saúde nas mídias digitais tem como objetivo garantir que as melhores informações sobre manejo e cuidado da COVID-19 cheguem às pessoas e promovam qualidade de vida.

Downloads

Não há dados estatísticos.

Biografia do Autor

Thais Ribeiro Pinto Bravo, Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde, Faculdade de Farmácia, Universidade Federal Fluminense

PhD student in the Postgraduate Program in Sciences Applied to Health Products at Universidade Federal Fluminense. Master in Science Applied to Health Products from Universidade Federal Fluminense (2020). Graduated in Pharmacy from Universidade Federal Fluminense (2019)

Alberto Calil Junior, Departamento de Biblioteconomia e do Programa de Pós-Graduação em Biblioteconomia - Universidade Federal do Estado do Rio de Janeiro.

Graduated in Librarianship and Documentation from the Fluminense Federal University (1993), Master's (2004) and Doctorate (2009) in Social Sciences from the State University of Rio de Janeiro. Associate Professor I of the Department of Library Science at the Federal University of the State of Rio de Janeiro (UNIRIO). He is currently a member of the Graduate Program in Library Science. He teaches subjects in the Graduate Program in Library Science and in the Graduate Program in Library Science at UNIRIO. 

Thaisa Amorim Nogueira, Faculdade de Farmácia, Universidade Federal Fluminense

Graduated in Pharmacy from Universidade Federal Fluminense (2007), Master in Applied Sciences to Health Products from Universidade Federal Fluminense (2012) and Ph.D. in Applied Sciences to Health Products from Universidade Federal Fluminense (2016). She is currently a professor at Faculty of Pharmacy at the Universidade Federal Fluminense. She works with drug information. 

Sabrina Calil-Elias, Faculdade de Farmácia, Universidade Federal Fluminense

Doctor and Master in Biological Sciences (Pharmacology and Medicinal Chemistry) from the Federal University of Rio de Janeiro, graduated in Industrial Pharmacy from the Fluminense Federal University. She is currently a Professor at the Fluminense Federal University and a member of the permanent staff of the Residency courses in Hospital Pharmacy and the postgraduate programs in Administration and Management of Pharmaceutical Assistance (Masters) and Science Applied to Health Products (Masters and Doctorate), all from the Faculty of Pharmacy at UFF. She works in research in the areas of Clinical Pharmacy and Pharmacology.

Referências

AL-BALUSHI, A. A. In the Era of Social Media: Is it time to establish a code of online ethical conduct for healthcare professionals? Sultan Qaboos University Medical Journal [SQUMJ], v. 20, n. 1, p. e25-28, 2020. DOI: https://doi.org/10.18295/squmj.2020.20.01.004. Available from: https://journals.squ.edu.om/index.php/squmj/article/view/3503. Accessed: 5 Feb. 2022.

ALI, I.; ALHARBI, O. M. L. COVID-19: Disease, management, treatment, and social impact. Science of The Total Environment, v. 728, p. 138861, 2020. DOI: https://doi.org/10.1016/j.scitotenv.2020.138861. Available from: https://www.sciencedirect.com/science/article/pii/S0048969720323780?via%3Dihub. Accessed: 5 Feb. 2022.

ATRI, D. et al. COVID-19 for the Cardiologist. JACC: Basic to Translational Science, v. 5, n. 5, p. 518–536, 2020. DOI: https://doi.org/10.1016/j.jacbts.2020.04.002. Available in: https://www.sciencedirect.com/science/article/pii/S2452302X20301571?via%3Dihub. Accessed on: 5 Feb. 2022.

BARCELOS, T. N. et al. Análise de fake news veiculadas durante a pandemia de COVID-19 no Brasil. Rev Panam Salud Publica, v. 45, p. e65, 2021. DOI: https://doi.org/10.26633/RPSP.2021.65. Available in: https://iris.paho.org/handle/10665.2/53907. Accessed on: 5 Feb. 2022.

BIREME. Biblioteca Regional de Medicina. Redes sociais e COVID-19: a contribuição da BIREME. 2020. Available in: https://boletin.bireme.org/pt/2020/05/02/redes-sociais-e-covid-19-a-contribuicao-da-bireme/. Accessed on: 28 Oct. 2021.

BRASIL. Ministério da Saúde. Agência Nacional de Vigilância Sanitária (ANVISA). RESOLUÇÃO - RDC Nº 351, DE 20 DE MARÇO DE 2020, dispõe sobre a atualização do Anexo I (Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial) da Portaria SVS/MS nº 344, de 12 de maio de 1998, e dá outras providências.

BRAVO, T. P. et al. Analysis of information related to chloroquine and ivermectin in the digital media Youtube and Instagram: Relation between Covid-19 and infodemic. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, v. 12, n. 4, p. 687, 2021. DOI: https://doi.org/10.30968/rbfhss.2021.124.0687. Available in: https://rbfhss.org.br/sbrafh/article/view/687. Accessed on: 5 Feb. 2022.

CINELLI, M. et al. The COVID-19 social media infodemic. Scientific Reports, v. 10, n. 1, p. 16598, 2020. DOI: https://doi.org/10.1038/s41598-020-73510-5. Available in: https://www.nature.com/articles/s41598-020-73510-5. Accessed on: 5 Feb. 2022.

CORRÊA, M. C. D. V.; VILARINHO, L.; BARROSO, W. B. G. Controvérsias em torno do uso experimental da cloroquina / hidroxicloroquina contra a Covid-19: “no magic bullet.” Physis: Revista de Saúde Coletiva, v. 30, n. 2, p. 0–2, 2020. DOI: https://doi.org/10.1590/S0103-73312020300217. Available in: https://www.scielosp.org/article/physis/2020.v30n2/e300217/pt/. Accessed on: 5 Feb. 2022.

DARIYA, B.; NAGARAJU, G. P. Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients. Cytokine & Growth Factor Reviews, v. 53, p.43-52, 2020. DOI: https://doi.org/10.1016/j.cytogfr.2020.05.001. Available in: https://www.sciencedirect.com/science/article/pii/S1359610120300782?via%3Dihub. Accessed on: 5 Feb. 2022.

FURLAN, L.; CARAMELLI, B. The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil. Lancet Regional Health. Americas, v. 4, p. 100089, 2021. DOI: https://doi.org/10.1016/j.lana.2021.100089. Available in: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00085-5/fulltext. Accessed on: 5 Feb. 2022.

HALLAL, P. C. SOS Brazil: science under attack. The Lancet, v. 397, n. 10272, p. 373–374, 2021. DOI: https://doi.org/10.1016/S0140-6736(21)00141-0. Available in: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00141-0/fulltext. Accessed on: 5 Feb. 2022.

HAMID, S.; MIR, M. Y.; ROHELA, G. K. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes and New Infections, v. 35, p. 100679, 2020. DOI: https://doi.org/10.1016/j.nmni.2020.100679. Available in: https://www.sciencedirect.com/science/article/pii/S2052297520300317?via%3Dihub. Accessed on: 5 Feb. 2022.

HAZZAM, J.; LAHRECH, A. Health Care Professionals’ Social Media Behavior and the Underlying Factors of Social Media Adoption and Use: Quantitative Study. Journal of medical Internet research, v. 20, n. 11, p. e12035, 2018. DOI: http://doi.org/10.2196/12035. Available in: https://www.jmir.org/2018/11/e12035/. Accessed on: 5 Feb. 2022.

LAMONTAGNE, F. et al. A living WHO guideline on drugs to prevent covid-19. BMJ, V. 372, p. n526, 2021. DOI: https://doi.org/10.1136/bmj.n526. Available in: https://www.bmj.com/content/372/bmj.n526. Accessed on: 5 Feb. 2022.

LI, X.; LI, T.; WANG, H. Treatment and prognosis of COVID-19: Current scenario and prospects (Review). Experimental and therapeutic medicine, v. 21, n. 1, p. 3, jan. 2021. DOI: https://doi.org/10.3892/etm.2020.9435. Available in: https://www.spandidos-publications.com/10.3892/etm.2020.9435. Accessed on: 5 Feb. 2022.

LOTFI, M.; HAMBLIN, M. R.; REZAEI, N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta, v. 508, p. 254–266, 2020. DOI: https://doi.org/10.1016/j.cca.2020.05.044. Available in: https://www.sciencedirect.com/science/article/pii/S0009898120302503?via%3Dihub. Accessed on: 5 Feb. 2022.

MIAN, A.; KHAN, S. Coronavirus: the spread of misinformation. BMC Medicine, v. 18, n. 89, p. 1-2, 2020. DOI: https://doi.org/10.1186/s12916-020-01556-3. Available in: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01556-3. Accessed on: 5 Feb. 2022.

MIGUEL, L.C.B.; CARVALHO, C.J.S. 2021. O impacto das fake news e a sua influência na automedicação na COVID. PubSaúde, v. 19, n. 5, p. 145, 2021. DOI: https://dx.doi.org/10.31533/pubsaude5.a145. Available in: https://pubsaude.com.br/revista/o-impacto-das-fake-news-e-a-sua-influencia-na-automedicacao-na-covid-19/. Accessed on: 5 Feb. 2022.

NUSSBAUMER-STREIT, B. et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews, v. 4, n. 4, p. CD013574, 2020. DOI: https://doi.org/10.1002/14651858.CD013574. Available in: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013574/full. Accessed on: 5 Feb. 2022.

PAHO. Pan American Health Organization. Entenda a Infodemia e a Desinformação na Luta Contra a COVID-19. 2020. Available in: https://iris.paho.org/bitstream/handle/10665.2/52054/Factsheet-Infodemic_por.pdf?sequence=16. Accessed on: 28 Oct. 2021.

PASSARINHO, N. Coronavírus: Chefes de UTIs ligam ‘kit Covid’ a maior risco de morte no Brasil. BCC News, 2021. Availabe in: https://www.bbc.com/portuguese/brasil-56457562. Accessed on: 28 Oct. 2021.

PEREIRA, D. B.; SILVA, E. P. da. Diretrizes para o uso das redes sociais pelas instituições arquivísticas brasileiras. Revista Acervo, v. 33, n. 3, p. 116–135, 2020. Available in: https://revista.an.gov.br/index.php/revistaacervo/article/view/1544. Accessed on: 5 Feb. 2022.

ROVETTA, A.; BHAGAVATHULA, A. S. COVID-19-Related Web Search Behaviors and Infodemic Attitudes in Italy: Infodemiological Study. JMIR Public Health and Surveillance, v. 6, n. 2, p. e19374, 2020. DOI: https://doi.org/10.2196/19374. Available in: https://publichealth.jmir.org/2020/2/e19374/. Accessed on: 5 Feb. 2022.

RUBERT, C. et al. Assistência farmacêutica durante a pandemia da covid-19: revisão da literatura. Revista Interdisciplinar de Ensino, Pesquisa e Extensão, v. 8, n. 1, p. 255-268, 2021. DOI: https://doi.org/10.33053/revint.v8i1.316. Available in: https://revistaeletronica.unicruz.edu.br/index.php/revint/article/view/316. Accessed on: 5 Feb. 2022.

SANTOS-PINTO, C. D. B.; MIRANDA, E. S.; OSORIO-DE-CASTRO, C. G. S. “Kit-covid” and the popular pharmacy program in Brazil. Cadernos de Saúde Pública, v. 37, n. 2, e00348020, 2021. DOI: https://doi.org/10.1590/0102-311X00348020. Available in: https://www.scielo.br/j/csp/a/KbTcQRMdhjHSt7PgdjLNJyg/?lang=en. Accessed on: 5 Feb. 2022.

SERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, v. 55, n. 6, p. 105969, 2020. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105969. Available in: https://www.sciencedirect.com/science/article/pii/S0924857920301266?via%3Dihub. Accessed on: 5 Feb. 2022.

SHEN, M. et al. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use. Vaccine, v. 39, n. 16, p. 2295–2302, 2021. DOI: https://doi.org/10.1016/j.vaccine.2021.02.056. Available in: https://www.sciencedirect.com/science/article/pii/S0264410X2100236X?via%3Dihub. Accessed on: 5 Feb. 2022.

SHETH, J. Impact of Covid-19 on Consumer Behavior: Will the Old Habits Return or Die? Journal of Business Research, v. 117, p. 280-283, 2020. DOI: https://doi.org/10.1016/j.jbusres.2020.05.059. Available in: https://www.sciencedirect.com/science/article/pii/S0148296320303647?via%3Dihub. Accessed on: 5 Feb. 2022.

SILVA, H. M. Medicines and illusions in the fight against COVID-19 in Brazil. Ethics, Medicine and Public Health, v. 16, p. 100622, 2021. DOI: https://doi.org/10.1016/j.jemep.2020.100622. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775660/. Accessed on: 5 Feb. 2022.

SINGH, L. et al. A first look at COVID-19 information and misinformation sharing on Twitter. Preprint. ArXiv. 2020; arXiv:2003.13907v1, 2020. Available in: https://arxiv.org/pdf/2003.13907.pdf. Accessed on: 5 Feb. 2022.

SOARES, F.B. et al. Infodemic and Instagram: how is the platform appropriated to produce disinformation about hydroxychloroquine? Rev Fronteiras, v. 23, n. 2, p. 89-103, 2021. DOI: https://doi.org/10.4013/fem.2021.232.07. Available in: http://revistas.unisinos.br/index.php/fronteiras/article/view/22581. Accessed on: 5 Feb. 2022.

TAPIA, L. COVID-19 and Fake News in the Dominican Republic. The American Journal of Tropical Medicine and Hygiene, v. 102, n. 6, p. 1172–1174, 2020. DOI: https://doi.org/10.4269/ajtmh.20-0234. Available in: https://www.ajtmh.org/view/journals/tpmd/102/6/article-p1172.xml. Accessed on: 5 Feb. 2022.

THE LANCET. COVID-19 in Brazil: “So what?” The Lancet, v. 395, n. 10235, p. 1461, 2020. DOI: https://doi.org/10.1016/s0140-6736(20)31095-3. Available in: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31095-3/fulltext. Accessed on: 5 Feb. 2022.

WANG, P. W. et al. COVID-19-Related Information Sources and the Relationship With Confidence in People Coping with COVID-19: Facebook Survey Study in Taiwan. Journal of medical Internet research, v. 22, n. 6, p. e20021–e20021, 5 jun. 2020. DOI: https://doi.org/10.2196/20021. Available in: https://www.jmir.org/2020/6/e20021/. Accessed on: 5 Feb. 2022.

WARDLE, C. Information Disorder: the essential glossary. Shorentein Center on Media, Politics and Public Policy. Harvard Kennedy School. 2018. Available in: https://firstdraftnews.org/wp-content/uploads/2018/07/infoDisorder_glossary.pdf Accessed on: 28 Oct. 2021.

WARDLE, C. Understanding information disorder. [S. l.]: Firstdraft, 2019. Available in: https://firstdraftnews.org/wp-content/uploads/2019/10/Information_Disorder_Digital_AW.pdf?x76701. Accessed on: 28 Oct. 2021.

WARDLE, C; DERAKSHAN, H. Reflexão sobre a “desordem da informação”: formatos da informação incorreta, desinformação e má-informação. Módulo 2. In: UNESCO. Jornalismo, “fake news” & desinformação: Manual para educação e treinamento em jornalismo. Brasília: UNESCO office Brasília, 2019. (Série UNESCO sobre Educação em Jornalismo). Available in: https://unesdoc.unesco.org/ark:/48223/pf0000368647. Accessed on: 5 Feb. 2022.

WASZAK, P. M.; KASPRZYCKA-WASZAK, W.; KUBANEK, A. The spread of medical fake news in social media – The pilot quantitative study. Health Policy and Technology, v. 7, n. 2, p. 115–118, 2018. DOI: https://doi.org/10.1016/J.HLPT.2018.03.002. Available in: https://www.sciencedirect.com/science/article/abs/pii/S2211883718300881?via%3Dihub. Accessed on: 5 Feb. 2022.

WHO. World Health Organization. Therapeutics and COVID-19: living guideline. 2021. Available in: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2021.3. Accessed on: 28 Oct 2021.

XAVIER, F. et al. Análise de redes sociais como estratégia de apoio a vigilância em saúde durante a Covid-19. Estudos Avançados, v. 34, n. 99, p. 261–282, 2020. DOI: https://doi.org/10.1590/s0103-4014.2020.3499.016. Available in: https://www.revistas.usp.br/eav/article/view/173428. Accessed on: 5 Feb. 2022.

YANG, K. C.; TORRES-LUGO, C.; MENCZER, F. Prevalence of Low-Credibility Information on Twitter During the COVID-19 Outbreak. Preprint. ArXiv. 2020; arXiv:2004.14484v2. DOI: 10.36190/2020.16. Available in: https://arxiv.org/abs/2004.14484. Accessed on: 5 Feb. 2022.

Downloads

Publicado

21-02-2022

Como Citar

BRAVO, T. R. P.; TEIXEIRA, R. G. da S. .; CALIL JUNIOR, A. C.; NOGUEIRA, T. A.; CALIL-ELIAS, S. Medicamentos e Infodemia: análise de mídias sociais no primeiro ano da pandemia de COVID-19. Revista Informação na Sociedade Contemporânea, [S. l.], v. 6, n. 1, p. e27214, 2022. DOI: 10.21680/2447-0198.2022v6n0ID27214. Disponível em: https://periodicos.ufrn.br/informacao/article/view/27214. Acesso em: 3 dez. 2024.

Edição

Seção

Artigos